The introduction of specific drugs for the treatment of pulmonary arterial hypertension over the last 20 years has led to an improvement of clinical and hemodynamic conditions and prognosis of affected patients. The use of combination therapy has made it possible to act simultaneously on several biological pathways involved in the etiopathogenesis of the disease. However, although the diagnosis and management have radically changed in recent years, the disease remains progressive and often fatal. The purpose of this paper is to review and discuss the results of the main clinical trials and the future perspectives of combination strategies for the treatment of pulmonary arterial hypertension.

La terapia di combinazione orale nel trattamento dei pazienti con ipertensione arteriosa polmonare. quali evidenze dagli studi a lungo termine [Oral combination therapy for the treatment of patients with pulmonary arterial hypertension. what evidence from long-term studies] / Pezzuto, Beatrice; Badagliacca, Roberto; Poscia, Roberto; Torre, Roberto; Ghio, Stefano; Scelsi, Laura; Greco, Alessandra; D'Alto, Michele; Argiento, Paola; Vitulo, Patrizio; Fedele, Francesco; Vizza, Carmine Dario. - In: GIORNALE ITALIANO DI CARDIOLOGIA. - ISSN 1827-6806. - ELETTRONICO. - 18:12(2017), pp. 854-861. [10.1714/2815.28469]

La terapia di combinazione orale nel trattamento dei pazienti con ipertensione arteriosa polmonare. quali evidenze dagli studi a lungo termine [Oral combination therapy for the treatment of patients with pulmonary arterial hypertension. what evidence from long-term studies]

Pezzuto, Beatrice;Badagliacca, Roberto;Poscia, Roberto;Torre, Roberto;Greco, Alessandra;Fedele, Francesco;Vizza, Carmine Dario
2017

Abstract

The introduction of specific drugs for the treatment of pulmonary arterial hypertension over the last 20 years has led to an improvement of clinical and hemodynamic conditions and prognosis of affected patients. The use of combination therapy has made it possible to act simultaneously on several biological pathways involved in the etiopathogenesis of the disease. However, although the diagnosis and management have radically changed in recent years, the disease remains progressive and often fatal. The purpose of this paper is to review and discuss the results of the main clinical trials and the future perspectives of combination strategies for the treatment of pulmonary arterial hypertension.
2017
pulmonary circulation; pulmonary hypertension; cardiology and cardiovascular medicine
01 Pubblicazione su rivista::01a Articolo in rivista
La terapia di combinazione orale nel trattamento dei pazienti con ipertensione arteriosa polmonare. quali evidenze dagli studi a lungo termine [Oral combination therapy for the treatment of patients with pulmonary arterial hypertension. what evidence from long-term studies] / Pezzuto, Beatrice; Badagliacca, Roberto; Poscia, Roberto; Torre, Roberto; Ghio, Stefano; Scelsi, Laura; Greco, Alessandra; D'Alto, Michele; Argiento, Paola; Vitulo, Patrizio; Fedele, Francesco; Vizza, Carmine Dario. - In: GIORNALE ITALIANO DI CARDIOLOGIA. - ISSN 1827-6806. - ELETTRONICO. - 18:12(2017), pp. 854-861. [10.1714/2815.28469]
File allegati a questo prodotto
File Dimensione Formato  
Pezzuto_Terapia-di-Combinazione_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 185.56 kB
Formato Adobe PDF
185.56 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1148722
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact